bexarotene has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baghdiguian, S; Commes, T; Leydet, A; Montero, JL; Winum, JY | 1 |
| di Martino, O; Ivan, DJ; Jurutka, PW; Khadka, I; Krall, TD; Le, A; Lee, IJ; Lee, MY; Liu, W; Mallick, S; Marshall, PA; Moen, GA; Noh, Y; Peoples, SJ; Perez, A; Petros, R; Reshi, S; Salama, E; Salama, J; Sausedo, MA; Savage, BM; Tromba, L; Wagner, CE; Welch, JS; Ziller, JW | 1 |
2 other study(ies) available for bexarotene and Leukemia
| Article | Year |
|---|---|
Synthesis of new Targretin analogues that induce apoptosis in leukemia HL-60 cells.
Topics: Anticarcinogenic Agents; Apoptosis; Bexarotene; Carbamates; HL-60 Cells; Humans; Leukemia; Receptors, Retinoic Acid; Retinoid X Receptors; Structure-Activity Relationship; Tetrahydronaphthalenes; Transcription Factors | 2002 |
An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Topics: Bexarotene; Humans; Leukemia; Liver X Receptors; Lymphoma, T-Cell, Cutaneous; Retinoid X Receptors; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Triglycerides | 2022 |